CDIO
Cardio Diagnostics Holdings, Inc. NASDAQ Listed Jan 14, 2022$1.82
Mkt Cap $3.4M
52w Low $0.97
12.2% of range
52w High $7.91
50d MA $2.76
200d MA $3.17
P/E (TTM)
-0.5x
EV/EBITDA
-0.1x
P/B
0.5x
Debt/Equity
0.1x
ROE
-93.2%
P/FCF
-0.8x
RSI (14)
—
ATR (14)
—
Beta
2.66
50d MA
$2.76
200d MA
$3.17
Avg Volume
3.7M
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
CIK (SEC)
Phone
855 226 9991
400 N Aberdeen St · Chicago, IL 60642 · US
Data updated apr 25, 2026 12:29am
· Source: massive.com